Glucocorticoid therapy as first-line treatment in primary hypophysitis: a systematic review and individual patient data meta-analysis

Glucocorticoid therapy as first-line treatment in primary hypophysitis: a systematic review and individual patient data meta-analysis

Objectives: High-dose glucocorticoids are associated with improved recover y of deficits in primary autoimmune hypophysitis (PAH), but optimal dosing, route, and duration are unclear. Design: We reviewed literature for first-line glucocorticoid treatment in PAH until December 2021 and performed an...

Full description

Bibliographic Details
Main Authors: Brijesh Krishnappa, Ravikumar Shah, Saba Samad Memon, Chakra Diwaker, Anurag R Lila, Virendra A Patil, Nalini S Shah, Tushar R Bandgar
Format: Article
Language:English
Published: Bioscientifica 2022-01-01
Series:Endocrine Connections
Subjects:
primary autoimmune hypophysitis
very high-dose glucocorticoids
duration of treatment
need for rescue therapy
intravenous glucocorticoids
Online Access:https://ec.bioscientifica.com/view/journals/ec/12/2/EC-22-0311.xml

Similar Items

Similar Items